U.S. Consumer Services Stock News

Asana (NYSE:ASAN) reported that its Asana Gov platform has achieved FedRAMP Moderate Authorization. This certification allows Asana Gov to be used by U.S. federal, state, and local government agencies, contractors, and educational institutions with defined security and compliance needs. The authorization marks an expansion of Asana's addressable market within regulated public sector environments. Asana is best known for its work management and collaboration software, used by teams to...

Sticky inflation, a higher for longer interest rate outlook from the Fed, and energy costs linked to Middle East tensions are reshaping how investors think about banks and insurance stocks. With headline inflation at 4.1% and core inflation at 3.4%, and no clear sign of quick rate relief, the cost of money and risk pricing are front and center again. This article looks at three large, financially healthy Financials stocks from our screener that appear well aligned with this backdrop, and...

Constellation Energy (NasdaqGS:CEG) has applied for 20-year license renewals for its Ginna and Nine Mile Point Unit 1 nuclear plants in New York. The proposed extensions would allow the reactors to operate until 2049, subject to regulatory approval. The plants are backed by New York's Zero Emissions Credit program, which supports carbon free generation. Constellation Energy is a major US producer of carbon free electricity, and its New York reactors are part of a broader focus on nuclear...

If you are wondering whether NBT Bancorp is still reasonably priced after its recent run, the current valuation picture offers a few clear clues and some gray areas worth unpacking. The stock last closed at US$49.26, with returns of 5.5% over 7 days, 5.8% over 30 days, 18.4% year to date, 22.2% over 1 year, 67.7% over 3 years, and 60.2% over 5 years, which naturally raises questions about what is already reflected in the price. Recent news around NBT Bancorp has focused on its position...

AdaptHealth (AHCO) shares moved after a Truist Securities analyst reiterated a positive rating following recent meetings with management, a reminder that investor sentiment often reacts quickly to updated views on a company’s outlook. See our latest analysis for AdaptHealth. At a share price of US$10.02, AdaptHealth has seen a 7 day share price return of 3.83%, but its 90 day share price return is down 10.54% and the 5 year total shareholder return is down 63.24%. This indicates that recent...

Extreme heat is moving from a long term climate concern to a very present investment issue for European markets, as record temperatures strain power grids, public services, and buildings that were never designed for this kind of weather. For investors, this raises practical questions about which stocks could see stronger demand from heat adaptation spending and where the risks might be rising. This article looks at three stocks exposed to the current European heatwave theme through their...

Enterprise AI is hitting a cost reality check as companies rein in token usage, push for cheaper models, and question how much they are willing to spend on premium providers like OpenAI and Anthropic. That puts cost-optimization software in the spotlight, as boards and finance teams look for clearer views on IT and AI spend, stronger controls, and better value from existing contracts. This article looks at 3 stocks from an Enterprise Cost-Optimization Software Providers screener that appear...

Datavault AI (DVLT) has drawn fresh attention after its WiSA Technologies division integrated the WiSA E Enterprise wireless audio module into Goldhorn's Goho LS7 home theater and karaoke systems, which are now available to consumers in China. See our latest analysis for Datavault AI. Despite the latest WiSA partnership win, Datavault AI’s recent share price performance has been weak, with the stock down 31.83% on a 30 day share price return basis and longer term total shareholder returns...

Daktronics (DAKT) has wrapped up FY 2026 with fourth quarter revenue of US$208.61 million and basic EPS of US$0.17, capping a year in which trailing twelve month revenue reached US$838.71 million and EPS came in at US$0.93 as net income totaled US$45.38 million. Over recent quarters, the company has seen quarterly revenue range from US$181.87 million to US$229.25 million, with basic EPS moving between US$0.06 and US$0.36. Together, these figures present a picture of earnings now contributing...

Corvus Pharmaceuticals (CRVS) has drawn investor interest after recent share price moves, with the stock last closing at $13.05 and a market value of about $1.09b. This highlights heightened attention on this clinical stage biopharma. See our latest analysis for Corvus Pharmaceuticals. Recent momentum in Corvus Pharmaceuticals has been strong, with a 7 day share price return of 9.57% and a year to date share price return of 78.28%. The 1 year total shareholder return of 209.98% points to a...

Cerebras Systems’ first post-IPO earnings report in June 2026 showed Q1 revenue rising to US$193.41 million, a narrower net loss of US$14.01 million, and new multi‑year AI infrastructure agreements with OpenAI and Amazon Web Services worth more than US$20 billion in aggregate. The company’s plan to lease back data center capacity as it pivots from selling chips to running an AI cloud points to a trade‑off between securing long‑term compute contracts and accepting lower gross margins in the...

Over the last 7 days, the United States market has experienced a 2.7% decline, yet it remains up 19% over the past year, with earnings projected to grow by 18% annually in the coming years. In this context of fluctuating short-term performance and strong long-term growth expectations, identifying undervalued stocks with discounted valuations can be an effective strategy for investors seeking to capitalize on potential market opportunities.

Over the last 7 days, the market has dropped 2.7%, contrasting with a 19% rise over the past year, and earnings are forecast to grow by 18% annually. In such a landscape, identifying stocks with strong financials becomes crucial for investors looking to capitalize on growth opportunities. While the term 'penny stocks' might seem outdated, these smaller or newer companies can offer unique value and growth potential when backed by solid fundamentals.

Over the last 7 days, the United States market has experienced a 2.7% drop, yet it remains up by 19% over the past year with expectations of an 18% annual earnings growth in the coming years. In this context, identifying growth companies with high insider ownership can be particularly appealing as they often align management interests with shareholders and may indicate confidence in future performance.

In the United States market, recent fluctuations have seen a 2.7% drop over the last week, yet it has achieved a notable 19% increase over the past year with earnings expected to grow by 18% annually. In such dynamic conditions, selecting reliable dividend stocks like International General Insurance Holdings can offer stability and potential income for investors seeking to balance growth with consistent returns.

With veteran investor Jeremy Grantham flagging U.S. stocks as extremely expensive based on the Buffett indicator, many investors are rethinking how much risk they really want in their portfolios. While the artificial intelligence boom has pushed market valuations higher and stirred talk of a possible bubble, some larger companies with historically low share price volatility and solid balance sheets may offer a different way to stay invested. This article looks at 3 stocks from our Low...

Brown & Brown (NYSE:BRO) has been recognized in 2026 for its workplace culture and mental health programs. The company was named to the Best Workplaces in Financial Services & Insurance and Best Workplaces for Mental Wellness lists. It also received the Platinum Level Bell Seal for Workplace Mental Health for the fourth consecutive year. Brown & Brown, trading at $60.83, is drawing attention for company culture as much as for its role in the insurance sector. The stock has risen 2.9% over...

In the past year, United States Antimony Corporation secured a US$27.0 million defense contract and reported a mining breakthrough, yet its financial results showed widening losses and repeated earnings misses. This contrast between promising operational announcements and weakening performance has raised questions about how effectively the company can translate opportunities into sustainable financial progress. We’ll now examine how this mix of new contracts and deteriorating results could...

Starwood Property Trust (NYSE:STWD) has launched a $500 million private offering of unsecured senior notes due 2029. The company intends to allocate the proceeds to eligible green and/or social projects under its sustainability framework. The transaction also includes plans to refinance or redeem certain existing debt obligations. Starwood Property Trust is adding a fresh layer to its funding mix with this sustainable bond issue, tying a sizeable portion of new capital to green and social...

H.B. Fuller (FUL) has just posted Q2 2026 results with revenue of US$950.3 million, Basic EPS of US$1.25 and net income excluding extra items of US$67.8 million, giving investors a clear look at how the business is performing at mid year. The company has seen quarterly revenue move from US$898.1 million in Q2 2025 to US$950.3 million in Q2 2026, while Basic EPS shifted from US$0.77 to US$1.25 over the same period. This sets the stage for investors to focus on how these results feed through to...

Polaris (NYSE:PII) has secured long-term funding dedicated to outdoor recreation initiatives across America's National Forests. The company announced that its Polaris Fund for Outdoor Recreation Grants is now fully endowed, providing ongoing support for conservation, access, and stewardship projects. Polaris also appointed Dustin J. Semach to its Board of Directors, adding industry and financial experience at an important moment for its governance. Polaris, known for its off-road vehicles,...

Earlier this week, ARS Pharmaceuticals reported that neffy, its epinephrine nasal spray, did not gain any new major commercial insurance coverage in the July 1, 2026 review cycle, though the company did secure additional Medicaid coverage and reduced its planned 2026 cash-based operating expenses. The update also included management’s reaffirmation that the existing neffy business underpins a path to cash-flow break-even in 2027, underscoring how payer access remains central to the company’s...

Hershey (NYSE:HSY) has appointed Heather Hoytink as President, U.S. Hoytink joins Hershey after a high-profile sales and commercial leadership career at PepsiCo. The appointment puts a new leader in charge of Hershey’s core U.S. business, which drives a large share of its revenue and product activity. For investors tracking Hershey at a share price of $176.68, this leadership change lands at a time when the stock has delivered mixed returns. HSY is up 2.3% over the past week and 9.0% over...

SpaceX’s plan to roll out a Starlink mobile service in the US puts fresh pressure on established telecom stocks, as a new competitor steps directly into the multibillion dollar phone network market. For investors, the story is less about rockets and more about how capital heavy network buildouts, spectrum needs, and changing consumer options could reshape parts of the US telecommunications sector. This article breaks down 3 stocks from our sector screener that are closely exposed to this...